U
BioElectronics Corporation
BIEL
$0.0001
-$0.0001-50.00%
D
Sell
3/14/2023Downgrade
BioElectronics Corporation (BIEL) was downgraded to D- from D on 3/14/2023 due to a decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to D- from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
BioElectronics Corporation (BIEL) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index.
D
Sell
2/8/2023Downgrade
BioElectronics Corporation (BIEL) was downgraded to D- from D on 02/08/2023.
BioElectronics Corporation (BIEL) was downgraded to D- from D on 02/08/2023.
D
Sell
5/5/2022Upgraded
BioElectronics Corporation (BIEL) was upgraded to D from D- on 05/05/2022.
BioElectronics Corporation (BIEL) was upgraded to D from D- on 05/05/2022.
D
Sell
4/20/2022Downgrade
BioElectronics Corporation (BIEL) was downgraded to D- from D on 04/20/2022.
BioElectronics Corporation (BIEL) was downgraded to D- from D on 04/20/2022.
D
Sell
11/23/2021Upgraded
BioElectronics Corporation (BIEL) was upgraded to D from D- on 11/23/2021.
BioElectronics Corporation (BIEL) was upgraded to D from D- on 11/23/2021.
D
Sell
11/8/2021Downgrade
BioElectronics Corporation (BIEL) was downgraded to D- from D on 11/8/2021 due to a large decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to D- from D on 11/8/2021 due to a large decline in the volatility index.
D
Sell
5/1/2020Downgrade
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 5/1/2020 due to a significant decline in the efficiency index and total return index.
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 5/1/2020 due to a significant decline in the efficiency index and total return index.
D
Sell
4/15/2020Downgrade
BioElectronics Corporation (BIEL) was downgraded to D+ from C- on 4/15/2020 due to a substantial decline in the solvency index.
BioElectronics Corporation (BIEL) was downgraded to D+ from C- on 4/15/2020 due to a substantial decline in the solvency index.
C
Hold
2/20/2020Downgrade
BioElectronics Corporation (BIEL) was downgraded to C- from C on 2/20/2020 due to a decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to C- from C on 2/20/2020 due to a decline in the volatility index.
C
Hold
2/5/2020Upgraded
BioElectronics Corporation (BIEL) was upgraded to C from C- on 2/5/2020 due to an increase in the volatility index, growth index and total return index.
BioElectronics Corporation (BIEL) was upgraded to C from C- on 2/5/2020 due to an increase in the volatility index, growth index and total return index.
C
Hold
1/17/2020Upgraded
BioElectronics Corporation (BIEL) was upgraded to C- from D+ on 1/17/2020 due to an increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to C- from D+ on 1/17/2020 due to an increase in the volatility index.
D
Sell
1/2/2020Downgrade
BioElectronics Corporation (BIEL) was downgraded to D+ from C- on 1/2/2020 due to a decline in the volatility index and growth index.
BioElectronics Corporation (BIEL) was downgraded to D+ from C- on 1/2/2020 due to a decline in the volatility index and growth index.
C
Hold
12/18/2019Upgraded
BioElectronics Corporation (BIEL) was upgraded to C- from D+ on 12/18/2019 due to an increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to C- from D+ on 12/18/2019 due to an increase in the volatility index.
D
Sell
12/17/2019Upgraded
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 12/17/2019 due to a significant increase in the efficiency index and growth index. Total revenue increased 133.73% from $141.1 to $329.8, EBIT increased 37.46% from -$316.9 to -$198.2, and net income increased 15.03% from -$563 to -$478.4.
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 12/17/2019 due to a significant increase in the efficiency index and growth index. Total revenue increased 133.73% from $141.1 to $329.8, EBIT increased 37.46% from -$316.9 to -$198.2, and net income increased 15.03% from -$563 to -$478.4.
D
Sell
12/5/2019Downgrade
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 12/5/2019 due to a noticeable decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 12/5/2019 due to a noticeable decline in the volatility index.
D
Sell
11/20/2019Upgraded
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 11/20/2019 due to an increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 11/20/2019 due to an increase in the volatility index.
D
Sell
11/5/2019Downgrade
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 11/5/2019 due to a decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 11/5/2019 due to a decline in the volatility index.
D
Sell
5/1/2019Upgraded
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 5/1/2019 due to an increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 5/1/2019 due to an increase in the volatility index.
D
Sell
4/16/2019Downgrade
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 4/16/2019 due to a decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 4/16/2019 due to a decline in the volatility index.
D
Sell
3/29/2019Upgraded
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 3/29/2019 due to an increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 3/29/2019 due to an increase in the volatility index.
D
Sell
3/13/2019Downgrade
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 3/13/2019 due to a decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 3/13/2019 due to a decline in the volatility index.
D
Sell
2/15/2019Upgraded
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 2/15/2019 due to a noticeable increase in the volatility index and growth index.
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 2/15/2019 due to a noticeable increase in the volatility index and growth index.
D
Sell
11/30/2018Downgrade
BioElectronics Corporation (BIEL) was downgraded to D from C on 11/30/2018 due to a significant decline in the efficiency index, growth index and volatility index. Total capital declined 87.85% from -$346.5 to -$650.9, and total revenue declined 28.45% from $296.3 to $212.
BioElectronics Corporation (BIEL) was downgraded to D from C on 11/30/2018 due to a significant decline in the efficiency index, growth index and volatility index. Total capital declined 87.85% from -$346.5 to -$650.9, and total revenue declined 28.45% from $296.3 to $212.
C
Hold
2/5/2018Upgraded
BioElectronics Corporation (BIEL) was upgraded to C from C- on 2/5/2018 due to an increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to C from C- on 2/5/2018 due to an increase in the volatility index.
C
Hold
1/19/2018Downgrade
BioElectronics Corporation (BIEL) was downgraded to C- from C on 1/19/2018 due to a noticeable decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to C- from C on 1/19/2018 due to a noticeable decline in the volatility index.
C
Hold
1/4/2018Upgraded
BioElectronics Corporation (BIEL) was upgraded to C from C- on 1/4/2018 due to a noticeable increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to C from C- on 1/4/2018 due to a noticeable increase in the volatility index.
C
Hold
12/5/2017Downgrade
BioElectronics Corporation (BIEL) was downgraded to C- from C on 12/5/2017 due to a noticeable decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to C- from C on 12/5/2017 due to a noticeable decline in the volatility index.
C
Hold
11/20/2017Upgraded
BioElectronics Corporation (BIEL) was upgraded to C from C- on 11/20/2017 due to an increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to C from C- on 11/20/2017 due to an increase in the volatility index.
C
Hold
10/24/2017Downgrade
BioElectronics Corporation (BIEL) was downgraded to C- from C on 10/24/2017 due to a decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to C- from C on 10/24/2017 due to a decline in the volatility index.
C
Hold
10/9/2017Upgraded
BioElectronics Corporation (BIEL) was upgraded to C from C- on 10/9/2017 due to a noticeable increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to C from C- on 10/9/2017 due to a noticeable increase in the volatility index.
C
Hold
9/22/2017Upgraded
BioElectronics Corporation (BIEL) was upgraded to C- from D on 9/22/2017 due to a significant increase in the efficiency index.
BioElectronics Corporation (BIEL) was upgraded to C- from D on 9/22/2017 due to a significant increase in the efficiency index.
D
Sell
8/29/2017Downgrade
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 8/29/2017 due to a noticeable decline in the efficiency index, volatility index and total return index.
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 8/29/2017 due to a noticeable decline in the efficiency index, volatility index and total return index.
D
Sell
4/24/2017Upgraded
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 4/24/2017 due to an increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 4/24/2017 due to an increase in the volatility index.
D
Sell
4/7/2017Downgrade
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 4/7/2017 due to a decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 4/7/2017 due to a decline in the volatility index.
D
Sell
2/6/2017Upgraded
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 2/6/2017 due to a noticeable increase in the volatility index, total return index and solvency index.
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 2/6/2017 due to a noticeable increase in the volatility index, total return index and solvency index.
D
Sell
12/1/2016Downgrade
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 12/1/2016 due to a decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 12/1/2016 due to a decline in the volatility index.
D
Sell
11/29/2016Downgrade
BioElectronics Corporation (BIEL) was downgraded to D+ from C- on 11/29/2016 due to a noticeable decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to D+ from C- on 11/29/2016 due to a noticeable decline in the volatility index.
C
Hold
11/14/2016Upgraded
BioElectronics Corporation (BIEL) was upgraded to C- from D+ on 11/14/2016 due to a noticeable increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to C- from D+ on 11/14/2016 due to a noticeable increase in the volatility index.
D
Sell
11/4/2016Upgraded
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 11/4/2016 due to an increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 11/4/2016 due to an increase in the volatility index.
D
Sell
10/20/2016Downgrade
BioElectronics Corporation (BIEL) was downgraded to D from C- on 10/20/2016 due to a large decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to D from C- on 10/20/2016 due to a large decline in the volatility index.
C
Hold
10/12/2016Upgraded
BioElectronics Corporation (BIEL) was upgraded to C- from D+ on 10/12/2016 due to a noticeable increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to C- from D+ on 10/12/2016 due to a noticeable increase in the volatility index.
D
Sell
10/11/2016Upgraded
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 10/11/2016 due to an increase in the volatility index.
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 10/11/2016 due to an increase in the volatility index.
D
Sell
9/26/2016Downgrade
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 9/26/2016 due to a decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 9/26/2016 due to a decline in the volatility index.
D
Sell
9/23/2016Downgrade
BioElectronics Corporation (BIEL) was downgraded to D+ from C- on 9/23/2016 due to a significant decline in the efficiency index and solvency index.
BioElectronics Corporation (BIEL) was downgraded to D+ from C- on 9/23/2016 due to a significant decline in the efficiency index and solvency index.
C
Hold
9/12/2016Downgrade
BioElectronics Corporation (BIEL) was downgraded to C- from C on 9/12/2016 due to a decline in the growth index and volatility index.
BioElectronics Corporation (BIEL) was downgraded to C- from C on 9/12/2016 due to a decline in the growth index and volatility index.
C
Hold
3/11/2016Downgrade
BioElectronics Corporation (BIEL) was downgraded to C from C+ on 3/11/2016 due to a major decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to C from C+ on 3/11/2016 due to a major decline in the volatility index.
C
Hold
11/18/2015Upgraded
BioElectronics Corporation (BIEL) was upgraded to C+ from C on 11/18/2015 due to a significant increase in the efficiency index, volatility index and total return index.
BioElectronics Corporation (BIEL) was upgraded to C+ from C on 11/18/2015 due to a significant increase in the efficiency index, volatility index and total return index.
C
Hold
8/12/2014Upgraded
BioElectronics Corporation (BIEL) was upgraded to C from D on 8/12/2014 due to an increase in the growth index and volatility index.
BioElectronics Corporation (BIEL) was upgraded to C from D on 8/12/2014 due to an increase in the growth index and volatility index.
D
Sell
6/17/2014Downgrade
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 6/17/2014 due to a large decline in the volatility index.
BioElectronics Corporation (BIEL) was downgraded to D from D+ on 6/17/2014 due to a large decline in the volatility index.
D
Sell
6/2/2014Upgraded
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 6/2/2014 due to a noticeable increase in the growth index, efficiency index and solvency index. Total capital increased 181% from $127.9 to $359.4, the quick ratio increased from 0.05 to 0.08, and total revenue increased 54.04% from $110.1 to $169.6.
BioElectronics Corporation (BIEL) was upgraded to D+ from D on 6/2/2014 due to a noticeable increase in the growth index, efficiency index and solvency index. Total capital increased 181% from $127.9 to $359.4, the quick ratio increased from 0.05 to 0.08, and total revenue increased 54.04% from $110.1 to $169.6.
D
Sell
2/28/2014Upgraded
BioElectronics Corporation (BIEL) was upgraded to D from on 2/28/2014 due to a significant increase in stability, solvency and valuation.
BioElectronics Corporation (BIEL) was upgraded to D from on 2/28/2014 due to a significant increase in stability, solvency and valuation.
OTC PK
04/02/2025 3:19PM Eastern
Quotes delayed
